NOV 29, 2022 6:00 AM PST

Bacterial or Viral? The added value of an innovative diagnostic solution for responsiveness when facing clinical uncertainties

Sponsored by: DiaSorin S.p.A.
Speakers
  • Emergency Pediatrician, Regina Margherita Children's Hospital, Turin-Italy
    BIOGRAPHY
  • Biology Consultant
    Department of Laboratory Medicine, University-Hospital, Padova-Italy
    QI.LAB.MED, University of Padova-Italy
    BIOGRAPHY

Abstract
Date:  November 29, 2022
Time: 6:00am (PST),  9:00am (EST), 3:00pm (CET)
 
Antimicrobial resistance is an emerging problem in healthcare, and represents one of the most crucial challenges for the decades ahead. Although several antimicrobial stewardship initiatives have been undertaken at different layers within the health care services structure, the pediatric setting proposes particular challenges that make the proper management of antibiotic therapy very complex. Furthermore, the COVID-19 pandemic has made matters worse, given the high reliance on telemedicine in pediatric patient assessment. It has therefore become crucial, especially in the emergency department, to correctly identify the nature of the infectious agent causing a patient’s clinical condition in order to determine whether or not empiric antibiotic therapy is required.
 
The hematochemical tests currently available to pediatricians, such as blood count with leukocyte formula, c-reactive protein, and procalcitonin, may not be sufficient when determining the specific type of infection. This can lead to an unwarranted over-prescription of antibiotic therapy.
 
Today, a novel signature assay quickly and accurately differentiates between bacterial and viral infections and can be run on fully automated, high-throughput testing platforms. This new diagnostic solution integrates the circulating levels of three host biomarkers to provide an easy-to-interpret score that helps clinicians expedite patient management and treatment decisions, especially in emergency settings.
 
Learning Objectives
  • Understand the challenge of antimicrobial resistance
  • Know clinical management of the pediatric patient with febrile illness
  • Learn advantages and limitations of current tests available in the emergency rooms
  • Understand the preliminary value of the new solution in the emergency setting
  • Know the analytical performances and technical features of the new diagnostic solution
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
SEP 28, 2022 9:00 AM PDT
SEP 28, 2022 9:00 AM PDT
Date: September 28, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) While COVID-19 continues to be the most pressing diagnostic focus for clinical laboratories, HIV remains a serious g...
JUN 29, 2022 8:00 AM PDT
JUN 29, 2022 8:00 AM PDT
Date: June 29, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) As of May 2022, there have been more than 500 million confirmed cases of COVID-19, including numerous variants. Additiona...
C.E. CREDITS
Date: October 25, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CEST) Candida auris is a multi-drug resistant yeast that continues to be a global threat for infection and transmission in h...
Loading Comments...
Show Resources